CCI approves Nirma's acquisition of Glenmark Life Sciences
The acquisition will trigger a mandatory open offer to all public shareholders of GLS for an additional 17%.
The acquisition will trigger a mandatory open offer to all public shareholders of GLS for an additional 17%.